ID
27408
Description
Study ID: 103094 Clinical Study ID: ARI103094 Study Title: ARI103094-Follow-Up Study for REDUCE Study Subjects Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: NCT00883909 Sponsor: GlaxoSmithKline Collaborators: N/A Phase: Phase 3 Study Recruitment Status: Completed Generic Name: dutasteride Trade Name: Zytefor,Zyfetor,Duagen,Avolve,Avodart,Avidart Study Indication: Neoplasms, Prostate
Keywords
Versions (3)
- 11/13/17 11/13/17 -
- 11/26/17 11/26/17 -
- 9/20/21 9/20/21 -
Copyright Holder
GlaxoSmithKline
Uploaded on
November 13, 2017
DOI
To request one please log in.
License
Creative Commons BY-NC 3.0
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
Prostatic Surgical Intervention GSK study Prostatic neoplasms NCT00883909
Prostatic Surgical Intervention GSK study Prostatic neoplasms NCT00883909
Description
Prostatic Surgical Intervention
Description
Prostate surgery
Description
Date of Prostate Surgery
Data type
date
Description
Time of Prostate Surgery
Data type
time
Description
BPH-related surgery
Data type
text
Description
Prostate Cancer-related surgery
Data type
text
Description
prostate surgery other indication
Data type
text
Description
prostate surgery other indication specification
Data type
text
Description
Please restrict the use of “Other”, especially if there is a more appropriate code listed above.
Data type
integer
Description
Other type of surgery
Data type
text